Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and breast cancer, and myeloma.
The increasing instances of surgical procedures, such as hip and knee replacements, will increase the risk of hypercalcemia and drive the growth prospects for the global hypercalcemia treatment market in the upcoming years. The study also shows that the prevalence of broken bone repair surgeries, cardiovascular procedures, percutaneous coronary interventions, joint replacement surgeries, knee replacement surgeries, hip replacement surgeries, and cases of coronary artery bypass grafting will increase the chances of developing hypercalcemia post surgeries. Consequently, the demand for hypercalcemia treatment drugs will also increase during the predicted period.

Market Analysis and Insights: Global Hypercalcemia Treatment Market
The global Hypercalcemia Treatment market size is projected to reach US$ 16410 million by 2027, from US$ 8956.6 million in 2020, at a CAGR of 8.6% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hypercalcemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hypercalcemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hypercalcemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hypercalcemia Treatment market.

Global Hypercalcemia Treatment Scope and Market Size
Hypercalcemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hypercalcemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bisphosphonates
Glucocorticoids
Calcimimetic Agents

Segment by Application
Mild Hypercalcemia
Moderate Hypercalcemia
Severe Hypercalcemia

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Amgen
Merck
Novartis
OPKO Health